Risk factor
Considerable default risk
Profitability factor
Slightly undervalued vs peers
About
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems....
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of f
Target Price
The average target price of IBAB.BR is 15 and suggests 2% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to dec
Buy
Sell